Author: Kelly Wiese Niemeyer

Researchers at WashU Medicine have identified a possible way to make brain cancer cells vulnerable to different types of immunotherapy, in hopes of finding new treatments for one of the most deadly cancers.

Researchers at WashU Medicine have found a process in which the brain guards against attack by the immune system, opening opportunities to pursue new therapies for diseases such as multiple sclerosis and Alzheimer’s.

At the WashU Board of Trustees meeting Sept. 27, numerous faculty members were granted tenure, effective that day.

A new study from WashU Medicine researchers finds that a type of immunotherapy — similar to one approved by the FDA to treat inflammatory conditions — may be an effective treatment strategy for heart failure.

Apryle M. Gladney has been appointed interim vice chancellor and chief human resources officer at WashU, announced Nichol Luoma, executive vice chancellor and chief administrative officer. Her new role took effect Oct. 15.

As part of WashU’s 10-year comprehensive evaluation, the Higher Learning Commission, the institutional accreditor, will host three open forums Oct. 28 and 29 to gather input from faculty, staff and students.

Doug E. Frantz has been appointed the new vice chancellor for innovation and commercialization at WashU, effective Jan. 1, according to Chancellor Andrew D. Martin and David H. Perlmutter, MD, executive vice chancellor for medical affairs and dean of the School of Medicine.

WashU’s Office of Information Security has recently revised and updated its policies to keep pace with the evolving digital landscape.

The east entrance and walkway connecting the Central West End MetroLink station platform with bus bays at the transit center, near the Medical Campus, will temporarily close at 6 p.m. Thursday, Oct. 17. They will reopen Monday, Oct. 21.

Images from on and around the WashU campuses.